News

Nuo Therapeutics Provides Corporate and Business Update

Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution…

2 years ago

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

InFoods® IBS commercial launch and revenues expected before the close of calendar year 2022Mr. Carlson is an accomplished and performance-driven…

2 years ago

Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

ISELIN, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch…

2 years ago

ADVANCED MEDTECH EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF GREG MILLER AS CHIEF FINANCIAL OFFICER

Singapore, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Advanced MedTech Holdings appoints US-based CFO with more than 35 years’ expertise in…

2 years ago

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein…

2 years ago

Alignment Healthcare to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

ORANGE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced…

2 years ago

Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health

Latest NeuroStar innovation to simplify the motor threshold determination for cliniciansMALVERN, Pa., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc.…

2 years ago

Galecto Announces Publication Supporting the Predictive Role of Galectin-3 on Overall Survival of NSCLC Patients in Peer-Reviewed Scientific Journal

BOSTON, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development…

2 years ago

Avricore Health Reports Second-Quarter 2022 Results

VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased…

2 years ago

ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization

SINGAPORE, Aug. 29, 2022 (GLOBE NEWSWIRE) -- ALR Technologies SG Pte. Ltd (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes…

2 years ago